Epstein Secrets

e relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confi

er Biden's "overseas business dealings...'Russian misinformation' just hours before Thursday evening's final presidential debate." Fox News (10/22, Wulfsohn, 27.59M) reports on its website that Bobulinski had been scheduled to attend the debate "as a special guest of President Trump." The New Ynrk Times

ents." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confid

g's final presidential debate." Fox News <https://www.foxnews.com/media/biden-campaign-trump-amplifying-russia-disinformation-hunter-biden> (10/22, Wulfsohn, 27.59M) reports on its website that Bobulinski had been scheduled to attend the debate "as a special guest of President Trump." The New York Times

e relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust and confi

er Biden's 'overseas business dealings...'Russian misinformation' just hours before Thursday evening's final presidential debate." Fox News (10/22, Wulfsohn, 27.59M) reports on its website that Bobulinski had been scheduled to attend the debate "as a special guest of President Trump." The New York Times

(11/30, Staff Writer) and The Epoch Times (11/30, Nguyen Ly). US Panel Backs First-Of-A-Kind COVID-19 Pill From Merck The Associated Press (11/30, Perrone) reported that a panel of Food and Drug Administration (FDA) health advisers voted 13-10 in support of Merck's new COVID-19 pill, molnupiravir, stat

11/30, Mullin), Reuters (11/30, Serjeant), CNN (11/30, Darcy, Stelter), NBC News (11/30, Stelloh), CBS News (11/30, Albert, Cates), Fox News (11/30, Wulfsohn), USA TODAY (11/30, Spector), Bloomberg (11/30, Eckhouse, Smith), Politico (11/30, Hooper), Forbes (11/30, Bissada), Newsweek (11/30, Villarreal),